ERIS LIFESCIENCES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 912.1 INR | +1.24% |
|
+0.48% | +0.23% |
| May. 22 | Eris Lifesciences Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
| May. 21 | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
Evolution of the average Target Price on Eris Lifesciences Limited
Price target over the last 5 years
History of analyst recommendation changes
d1ff5530b91aec897e292f.NWhepFLlIv2RKuDgF1_cLByJUeawlL35Q0h-gT4VkIo.dCYT5mfRFpr8Y6jUcAClf1PufKTK8vWwDB4tzkRt0e9wXT_GOIhqmcZMlw~90a98dc6fa8708762c6fe598ecd2fd3a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
901
INR
Average target price
1,106
INR
Spread / Average Target
+22.77%
High Price Target
1,270
INR
Spread / Highest target
+40.96%
Low Price Target
950
INR
Spread / Lowest Target
+5.44%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERIS Stock
- Consensus Eris Lifesciences Limited
